Abstract
Objective: Trauma-focused psychotherapies are first-line treatments for posttraumatic stress disorder (PTSD). For veterans, however, response rates are low, and dropout tends to be high. Some evidence suggests that those with comorbid depression are less likely to complete treatment and improve less in trauma-focused treatments. This study examined treatment noncompletion and PTSD symptom outcomes among veterans with and without comorbid major depressive disorder (MDD) treated for PTSD with either a trauma-focused psychotherapy (prolonged exposure [PE]) or a non-trauma-focused psychotherapy (interpersonal psychotherapy [IPT]). We also examined depressive symptoms as an outcome.
Methods: We conducted a secondary analysis of data from a randomized controlled trial comparing PE and IPT for the treatment of PTSD in veterans. Among 109 veterans starting treatment, 30 (52%) of 58 IPT patients and 21 (41%) of 51 PE patients were diagnosed with MDD. Those completing fewer than 8 sessions were considered noncompleters. Outcomes within each treatment and between treatments were compared by MDD status.
Results: There were no differences in noncompletion by MDD status in IPT. In PE, failure to complete was numerically but nonsignificantly higher in those without MDD. MDD was associated with significantly less PTSD symptom improvement in PE (P=.04) but not in IPT at the end of treatment. Findings from a linear model incorporating posttreatment follow-up data, although not statistically significant, were consistent with the end-of-treatment findings. Comparisons between treatments among those with MDD showed partial support for an advantage of IPT for PTSD symptom improvement. There were no differences between the treatments in change in symptoms of depression.
Conclusions: Findings are consistent with prior research showing that depression is associated with less PTSD symptom improvement in PE, a trauma-focused psychotherapy, but does not affect PTSD outcome in IPT. Although in need of replication in studies designed and statistically powered to test the role of MDD in PTSD treatment outcome, findings suggest a possible advantage for IPT relative to trauma-focused treatment for PTSD for those with comorbid MDD.
Trial Registration: ClinicalTrials.gov identifier: NCTO2586064.
J Clin Psychiatry 2026;87(3):25m16236
Author affiliations are listed at the end of this article.
Members Only Content
This full article is available exclusively to Professional tier members. Subscribe now to unlock the HTML version and gain unlimited access to our entire library plus all PDFs. If you're already a subscriber, please log in below to continue reading.
References (23)
- Hamblen JL, Norman SB, Sonis J, et al. A guide to guidelines for the treatment of posttraumatic stress disorder in adults: an update. Psychotherapy. 2019;56(3):359–373. PubMed CrossRef
- Larsen SE, Bellmore A, Gobin RL, et al. An initial review of residual symptoms after empirically supported trauma-focused cognitive behavioral psychological treatment. J Anxiety Disord. 2019;63:26–35. PubMed CrossRef
- Levi O, Ben Yehuda A, Pine DS, et al. A sobering look at treatment effectiveness of military-related posttraumatic stress disorder. Clin Psychol Sci. 2021;10(4):690–699. CrossRef
- Steenkamp MM, Litz BT, Hoge CW, et al. Psychotherapy for military-related PTSD: a review of randomized clinical trials. JAMA. 2015;314(5):489–500. PubMed CrossRef
- Belsher BE, Beech E, Evatt D, et al. Present-Centered Therapy (PCT) for posttraumatic stress disorder (PTSD) in adults. Cochrane Database Syst Rev. 2019. PubMed CrossRef
- Edwards-Stewart A, Smolenski DJ, Bush NE, et al. Posttraumatic stress disorder treatment dropout among military and veteran populations: a systematic review and meta-analysis. J Trauma Stress. 2021;34(4):808–818. PubMed CrossRef
- Schnurr PP, Chard KM, Ruzek JI, et al. Comparison of prolonged exposure vs cognitive processing therapy for treatment of posttraumatic stress disorder among US Veterans: a randomized clinical trial. JAMA Netw Open. 2022;5(1):e2136921. PubMed CrossRef
- Rytwinski NK, Scur MD, Feeny NC, et al. The co-occurrence of major depressive disorder among individuals with posttraumatic stress disorder: a meta-analysis. J Trauma Stress. 2013;26(3):299–309. PubMed CrossRef
- Bedard-Gilligan M, Duax Jacob JM, Doan LS, et al. An investigation of depression, trauma history, and symptom severity in individuals enrolled in a treatment trial for chronic PTSD. J Clin Psychol. 2015;71:725–7401. PubMed
- Kline AC, Cooper AA, Rytwinski NK, et al. The effect of concurrent depression on PTSD outcomes in trauma-focused psychotherapy: a meta-analysis of randomized controlled trials. Behav Ther. 2021;52(1):250–266. PubMed CrossRef
- Klerman G, Weissman MM, Rounsaville BJ, et al. Interpersonal psychotherapy for depression. Basic Books; 1987.
- Krupnick JL, Meinikoff E, Reinhard M. A pilot study of interpersonal psychotherapy for PTSD in women veterans. Psychiatry. 2016;79(1):56–69. PubMed CrossRef
- Markowitz JC. Interpersonal psychotherapy for posttraumatic stress disorder. Oxford University Press; 2016. CrossRef
- Markowitz J, Petkov AE, Neria Y, et al. Is exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD. Am J Psychiatr. 2015;172:430. PubMed
- Foa EB, Hembree EA, Rothbaum BO. Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences: Therapist Guide. Oxford University Press; 2007.
- Blake DD, Weathers FW, Nagy LM, et al. The development of a clinician-administered PTSD scale. J Trauma Stress. 1995;8(1):75–90. PubMed CrossRef
- Shea MT, Krupnick JL, Sautter FJ, et al. A randomized clinical trial comparing Interpersonal Psychotherapy with Prolonged Exposure for the treatment of PTSD in veterans. J Anxiety Disord. 2023;99:102770. PubMed CrossRef
- Shea MT, Krupnick JL, Sautter FJ, et al. Rationale, design, and methods of a two-site randomized controlled trial: comparative effectiveness of two treatments for posttraumatic stress disorder in veterans. Contemp Clin Trials. 2021;105:106408. PubMed CrossRef
- Weathers FW, Bovin MJ, Lee DJ, et al. The Clinician-Administered PTSD Scale for DSM-5 (CAPS-5): Development and initial psychometric evaluation in military veterans. Psychol Assess. 2018;30(3):383–395. PubMed CrossRef
- Schnurr PP, Lunney CA. Symptom benchmarks of improved quality of life in PTSD. Depress Anxiety. 2016;33(3):247–255. PubMed CrossRef
- First MB, Williams JBW, Karg RS, et al. Structured clinical interview for DSM-5 biometrics research. New York State Psychiatric Institute; 2014.
- Kroenke K, Spitzer RL, Williams JBW. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606–613. PubMed CrossRef
- Eftekhari A, Ruzek JI, Crowley JJ, et al. Effectiveness of national implementation of prolonged exposure therapy in Veterans Affairs care. JAMA Psychiatry. 2013;70(9):949–955. PubMed CrossRef
